HOOKIPA Pharma Inc.·4

Mar 23, 4:31 PM ET

SOFINNOVA CAPITAL VI FCPR 4

4 · HOOKIPA Pharma Inc. · Filed Mar 23, 2021

Insider Transaction Report

Form 4
Period: 2021-03-19
Transactions
  • Sale

    Common Stock

    2021-03-19$14.60/sh166,230$2,427,7393,739,964 total
Footnotes (2)
  • [F1]Shares sold pursuant to a Rule 10b5-1 trading plan dated September 30, 2020 previously adopted by the Reporting Person.
  • [F2]Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.

Documents

1 file
  • 4
    tm2110522-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT